Kinase inhibitors in thyroid cancers

OBJECTIVE: The treatment landscape for thyroid cancers has changed rapidly with the availability of kinase inhibitors against VEGFR, BRAF, MEK, NTRK, and RET. We provide an up-to-date review of the role of kinase inhibitors in thyroid cancer and discuss upcoming trials. DESIGN & METHODS: A compr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukrithan, Vineeth, Jain, Prachi, Shah, Manisha H, Konda, Bhavana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305552/
https://www.ncbi.nlm.nih.gov/pubmed/37434642
http://dx.doi.org/10.1530/EO-22-0062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305552/
https://www.ncbi.nlm.nih.gov/pubmed/37434642
http://dx.doi.org/10.1530/EO-22-0062

Ejemplares similares